Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

LA JOLLA, Calif., Oct. 22, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the Dawson James Securities 5th?Annual Small Cap Growth Conference being held on October 28-29, 2019 at the Wyndham Grand Hotel in Jupiter, Florida.